These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
260 related articles for article (PubMed ID: 22650169)
1. Recent and future antiepileptic drugs and their impact on cognition: what can we expect? Mula M Expert Rev Neurother; 2012 Jun; 12(6):667-71. PubMed ID: 22650169 [TBL] [Abstract][Full Text] [Related]
2. Pharmacotherapy of the third-generation AEDs: lacosamide, retigabine and eslicarbazepine acetate. Patsalos PN; Berry DJ Expert Opin Pharmacother; 2012 Apr; 13(5):699-715. PubMed ID: 22404663 [TBL] [Abstract][Full Text] [Related]
3. Practical Use of Newer Antiepileptic Drugs as Adjunctive Therapy in Focal Epilepsy. Brodie MJ CNS Drugs; 2015 Nov; 29(11):893-904. PubMed ID: 26507832 [TBL] [Abstract][Full Text] [Related]
4. New and forthcoming anti-epileptic drugs. Prunetti P; Perucca E Curr Opin Neurol; 2011 Apr; 24(2):159-64. PubMed ID: 21301338 [TBL] [Abstract][Full Text] [Related]
5. Progress report on new antiepileptic drugs: a summary of the Tenth Eilat Conference (EILAT X). Bialer M; Johannessen SI; Levy RH; Perucca E; Tomson T; White HS Epilepsy Res; 2010 Dec; 92(2-3):89-124. PubMed ID: 20970964 [TBL] [Abstract][Full Text] [Related]
10. Third generation antiepileptic drug monotherapies in adults with epilepsy. Mula M Expert Rev Neurother; 2016 Sep; 16(9):1087-92. PubMed ID: 27248204 [TBL] [Abstract][Full Text] [Related]
11. EpiTrack: tracking cognitive side effects of medication on attention and executive functions in patients with epilepsy. Lutz MT; Helmstaedter C Epilepsy Behav; 2005 Dec; 7(4):708-14. PubMed ID: 16266826 [TBL] [Abstract][Full Text] [Related]
12. Adjunctive use of ezogabine/retigabine with either traditional sodium channel blocking antiepileptic drugs (AEDs) or AEDs with other mechanisms of action: Evaluation of efficacy and tolerability. Brodie MJ; French JA; McDonald SA; Lee WJ; Adams B; Scott A; Nohria V; DeRossett S Epilepsy Res; 2014 Jul; 108(5):989-94. PubMed ID: 24726452 [TBL] [Abstract][Full Text] [Related]
13. Perspectives on treatment options for mesial temporal lobe epilepsy with hippocampal sclerosis. Palleria C; Coppola A; Citraro R; Del Gaudio L; Striano S; De Sarro G; Russo E Expert Opin Pharmacother; 2015; 16(15):2355-71. PubMed ID: 26328621 [TBL] [Abstract][Full Text] [Related]
14. Retigabine/Ezogabine, a KCNQ/K(V)7 channel opener: pharmacological and clinical data. Orhan G; Wuttke TV; Nies AT; Schwab M; Lerche H Expert Opin Pharmacother; 2012 Aug; 13(12):1807-16. PubMed ID: 22783830 [TBL] [Abstract][Full Text] [Related]
15. New drugs for pediatric epilepsy. Chu-Shore CJ; Thiele EA Semin Pediatr Neurol; 2010 Dec; 17(4):214-23. PubMed ID: 21183127 [TBL] [Abstract][Full Text] [Related]
16. Cognitive and memory effects of the new antiepileptic drugs. Meador KJ Epilepsy Res; 2006 Jan; 68(1):63-7. PubMed ID: 16377148 [TBL] [Abstract][Full Text] [Related]
17. Novel medications for epilepsy. Fattore C; Perucca E Drugs; 2011 Nov; 71(16):2151-78. PubMed ID: 22035515 [TBL] [Abstract][Full Text] [Related]
18. New antiepileptic drugs: focus on ezogabine, clobazam, and perampanel. Rudzinski LA; Vélez-Ruiz NJ; Gedzelman ER; Mauricio EA; Shih JJ; Karakis I J Investig Med; 2016 Aug; 64(6):1087-101. PubMed ID: 27252470 [TBL] [Abstract][Full Text] [Related]
19. Beneficial Combination of Lacosamide with Retigabine in Experimental Animals: An Isobolographic Analysis. Luszczki JJ; Zagaja M; Miziak B; Kondrat-Wrobel MW; Zaluska K; Wroblewska-Luczka P; Adamczuk P; Czuczwar SJ; Florek-Luszczki M Pharmacology; 2018; 101(1-2):22-28. PubMed ID: 28926841 [TBL] [Abstract][Full Text] [Related]
20. Evaluating the longer-term cognitive effects of adjunctive perampanel compared to lacosamide in a naturalistic outpatient setting. Meschede C; Witt JA; Rademacher M; von Wrede RD; Elger CE; Helmstaedter C Seizure; 2018 May; 58():141-146. PubMed ID: 29704679 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]